Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
BJU International
|
November 19, 2020
The obesity paradox: defining the impact of body mass index and diabetes mellitus for patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin
Nathan A Brooks, Andrea Kokorovic, Lianchen Xiao, et al.
The Prostate
|
October 21, 2015
Predictors of biochemical recurrence in pT3b prostate cancer after radical prostatectomy without adjuvant radiotherapy
Matthew J Pagano, Michael J Whalen, David J Paulucci, et al.
Annals of Surgical Oncology
|
July 30, 2024
The Influence of Disparities on Prostate Cancer at Diagnosis in the Charlotte Metropolitan Area
Alexis M Holland, Hadley H Wilson, Benjamin C Gambill, et al.
Urologic Oncology
|
July 16, 2023
Persistent opioid and benzodiazepine use after radical cystectomy in enhanced recovery after surgery (ERAS) patients
Samuel J Ivan, Hailey W Holck, Myra M Robinson, et al.
Urologic Oncology
|
June 6, 2022
Identification of potential biomarkers and novel therapeutic targets through genomic analysis of small cell bladder carcinoma and associated clinical outcomes
Earle F Burgess, J Alexa Sanders, Chad Livasy, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
July 12, 2024
Reduced Dose Intravesical Bacillus Calmette-Guérin: Why It Might Not Matter
Ashish M Kamat, Niyati Lobo, Seth P Lerner, et al.
The Journal of Urology
|
February 11, 2018
Discordance between Ureteroscopic Biopsy and Final Pathology for Upper Tract Urothelial Carcinoma
Ezra J Margolin, Justin T Matulay, Gen Li, et al.
Translational Andrology and Urology
|
August 25, 2021
Genomic analysis of response to bacillus Calmette-Guérin (BCG) treatment in high-grade stage 1 bladder cancer patients
J Alexa Sanders, Connor Frasier, Justin T Matulay, et al.
Urologic Oncology
|
May 21, 2020
Variability in adherence to guidelines based management of nonmuscle invasive bladder cancer among Society of Urologic Oncology (SUO) members
Justin T Matulay, William Tabayoyong, Jonathan J Duplisea, et al.
Cell
|
April 7, 2018
Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer
Suk Hyung Lee, Wenhuo Hu, Justin T Matulay, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
BJU International
|
November 19, 2020
The obesity paradox: defining the impact of body mass index and diabetes mellitus for patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin
Nathan A Brooks, Andrea Kokorovic, Lianchen Xiao, et al.
The Prostate
|
October 21, 2015
Predictors of biochemical recurrence in pT3b prostate cancer after radical prostatectomy without adjuvant radiotherapy
Matthew J Pagano, Michael J Whalen, David J Paulucci, et al.
Annals of Surgical Oncology
|
July 30, 2024
The Influence of Disparities on Prostate Cancer at Diagnosis in the Charlotte Metropolitan Area
Alexis M Holland, Hadley H Wilson, Benjamin C Gambill, et al.
Urologic Oncology
|
July 16, 2023
Persistent opioid and benzodiazepine use after radical cystectomy in enhanced recovery after surgery (ERAS) patients
Samuel J Ivan, Hailey W Holck, Myra M Robinson, et al.
Urologic Oncology
|
June 6, 2022
Identification of potential biomarkers and novel therapeutic targets through genomic analysis of small cell bladder carcinoma and associated clinical outcomes
Earle F Burgess, J Alexa Sanders, Chad Livasy, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
July 12, 2024
Reduced Dose Intravesical Bacillus Calmette-Guérin: Why It Might Not Matter
Ashish M Kamat, Niyati Lobo, Seth P Lerner, et al.
The Journal of Urology
|
February 11, 2018
Discordance between Ureteroscopic Biopsy and Final Pathology for Upper Tract Urothelial Carcinoma
Ezra J Margolin, Justin T Matulay, Gen Li, et al.
Translational Andrology and Urology
|
August 25, 2021
Genomic analysis of response to bacillus Calmette-Guérin (BCG) treatment in high-grade stage 1 bladder cancer patients
J Alexa Sanders, Connor Frasier, Justin T Matulay, et al.
Urologic Oncology
|
May 21, 2020
Variability in adherence to guidelines based management of nonmuscle invasive bladder cancer among Society of Urologic Oncology (SUO) members
Justin T Matulay, William Tabayoyong, Jonathan J Duplisea, et al.
Cell
|
April 7, 2018
Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer
Suk Hyung Lee, Wenhuo Hu, Justin T Matulay, et al.
Page
of 5